azimexon and tuftsin
azimexon has been researched along with tuftsin in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Giroud, JP; Moachon, L; Roch-Arveiller, M; Tissot, M | 1 |
Hadden, JW | 1 |
Chirigos, MA | 1 |
Bruley-Rosset, M; Florentin, I; Kiger, N; Martinez, J; Mathé, G; Schulz, J | 1 |
Bruley-Rosset, M; Florentin, I; Goutner, A; Mathé, G; Serrou, B | 1 |
Other Studies
5 other study(ies) available for azimexon and tuftsin
Article | Year |
---|---|
Effect of immunomodulating agents on leucocyte chemotaxis and cyclic nucleotides.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic GMP; Immunity; Inosine Pranobex; Leukocytes; Levamisole; Rats; Tuftsin | 1982 |
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
Overview of chemicals and biologicals capable of regulating immunity.
Topics: Adjuvants, Immunologic; Animal Diseases; Animals; Aziridines; Carboxymethylcellulose Sodium; Cimetidine; Humans; Hypoxanthines; Imidazoles; Immunity; Inosine Pranobex; Levamisole; Poly I-C; Polylysine; Pyran Copolymer; Tuftsin | 1984 |
In vivo immunomodulating properties of two synthetic agents: azimexon and tuftsin.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Aziridines; Azirines; Female; Hypersensitivity, Delayed; Immunoglobulin Fragments; Lymphocytes; Macrophages; Mice; Mitogens; Spleen; Tuftsin | 1980 |
Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Topics: Adjuvants, Immunologic; Animals; Aziridines; Azirines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Immunoglobulin Fragments; Immunotherapy; Leucine; Mice; Neoplasms, Experimental; T-Lymphocytes; Tuftsin | 1982 |